{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:18:33Z","timestamp":1768274313382,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.humimm.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T01:13:30Z","timestamp":1652318010000},"page":"574-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Increased frequency of activated regulatory T cells in patients with lupus nephritis"],"prefix":"10.1016","volume":"83","author":[{"given":"Elham","family":"Pourreza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mirzakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnaz","family":"Yousefghahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roghayeh","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshid","family":"Oliaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mousa","family":"Mohammadnia-Afrouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2022.05.001_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2018.11.001","article-title":"Signaling lymphocyte activation molecule family in systemic lupus erythematosus","volume":"204","author":"Comte","year":"2019","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.humimm.2022.05.001_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","article-title":"T cells in systemic lupus erythematosus","volume":"43","author":"Su\u00e1rez-Fueyo","year":"2016","journal-title":"Current opinion in immunology"},{"issue":"22","key":"10.1016\/j.humimm.2022.05.001_b0015","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"8","key":"10.1016\/j.humimm.2022.05.001_b0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nature reviews Nephrology"},{"key":"10.1016\/j.humimm.2022.05.001_b0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clinical immunology"},{"issue":"5","key":"10.1016\/j.humimm.2022.05.001_b0030","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1002\/jcp.27480","article-title":"Immunological biomarkers of tolerance in human kidney transplantation: An updated literature review","volume":"234","author":"Mirzakhani","year":"2019","journal-title":"Journal of cellular physiology"},{"issue":"3","key":"10.1016\/j.humimm.2022.05.001_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2478\/rir-2021-0021","article-title":"CD8+ T regulatory cells in lupus","volume":"2","author":"Singh","year":"2021","journal-title":"Rheumatology and Immunology Research"},{"issue":"4","key":"10.1016\/j.humimm.2022.05.001_b0040","doi-asserted-by":"crossref","first-page":"e34662","DOI":"10.1371\/journal.pone.0034662","article-title":"Increased CD45RA+ FOXP3 low regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus","volume":"7","author":"Pan","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.humimm.2022.05.001_b0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fimmu.2019.00159","article-title":"The regulatory T cell in active systemic lupus erythematosus patients: a systemic review and meta-analysis","volume":"10","author":"Li","year":"2019","journal-title":"Frontiers in immunology"},{"issue":"6","key":"10.1016\/j.humimm.2022.05.001_b0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.humimm.2022.05.001_b0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"10.1016\/j.humimm.2022.05.001_b0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the sledai. A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.humimm.2022.05.001_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4189","article-title":"Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis","volume":"15","author":"Dolff","year":"2013","journal-title":"Arthritis research & therapy"},{"issue":"2","key":"10.1016\/j.humimm.2022.05.001_b0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"Journal of Modern Applied Statistical Methods"},{"key":"10.1016\/j.humimm.2022.05.001_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3419565","article-title":"CD4 + CD45RA \u2212 FOXP3 low Regulatory T Cells as Potential Biomarkers of Disease Activity in Systemic Lupus Erythematosus Brazilian Patients","volume":"2018","author":"Silva-Neta","year":"2018","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1016\/j.humimm.2022.05.001_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-10-5","article-title":"Low frequency of CD4+ CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGF\u03b2 gene variants","volume":"10","author":"Barreto","year":"2009","journal-title":"BMC immunology"},{"issue":"9","key":"10.1016\/j.humimm.2022.05.001_b0085","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"10.1016\/j.humimm.2022.05.001_b0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"Anders","year":"2020","journal-title":"Lupus nephritis. Nature reviews Disease primers"},{"issue":"2","key":"10.1016\/j.humimm.2022.05.001_b0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2567.2008.02937.x","article-title":"Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus","volume":"127","author":"Suen","year":"2009","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.humimm.2022.05.001_b0100","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5603\/FHC.2011.0088","article-title":"Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus","volume":"49","author":"Kleczynska","year":"2011","journal-title":"Folia Histochemica et Cytobiologica"},{"issue":"4","key":"10.1016\/j.humimm.2022.05.001_b0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00296-010-1771-0","article-title":"Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis","volume":"32","author":"Xing","year":"2012","journal-title":"Rheumatology international"},{"issue":"3","key":"10.1016\/j.humimm.2022.05.001_b0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cei.13196","article-title":"Facilitated expansion of Th17 cells in lupus nephritis patients","volume":"194","author":"Jakiela","year":"2018","journal-title":"Clinical & Experimental Immunology"},{"key":"10.1016\/j.humimm.2022.05.001_b0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2021.619268","article-title":"Sex hormones and gender influence the expression of markers of regulatory T cells in SLE patients","volume":"12","author":"Singh","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1016\/j.humimm.2022.05.001_b0120","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/ard.2007.083543","article-title":"Clinical significance of increased CD4+ CD25\u2212 Foxp3+ T cells in patients with new-onset systemic lupus erythematosus","volume":"67","author":"Zhang","year":"2008","journal-title":"Annals of the rheumatic diseases"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:22Z","timestamp":1759319722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0198885922001161"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.05.001","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased frequency of activated regulatory T cells in patients with lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}